Pharma Stocks Outlook For The Week – 18 to 22.12.2017
The stocks of pharmaceutical companies are seen rising next week due to likely buying-on-dips by investors. Long term investors should use any rise in these stocks to sell their positions, as the
medium-term trend for the sector remains negative. Pharmaceutical companies have been among the worst performers this year, as increased pricing pressure in their largest drug market, the US and heightened regulatory scrutiny in recent years have suppressed revenues and profit margins. We may see a relief rally in the short term, but investors May outperform benchmarks, snap 7- week trend should sell on those rallies. The government plans to make it mandatory for chemists at pharmacy shops to inform patients about the generic drug substitute for a branded drug are likely to weigh on these stocks. Buying by mutual funds is expected next week, with mid-cap pharmaceutical companies being preferred over their large-cap peers.
Source : Cogencis Information Services Ltd.
Free Stock Options :Register To Get 2 days Trial Tips
Equity Cash/Futures/Options Segment
Register for Daily Rs 2000/- Profit in Stock Options
Click Here : Free Nifty Intraday Chart Live
Today Nifty Stocks Support and Resistance Level
Today Free Nifty Option Tips
Today Free Banknifty Option Tips
Today Free Stock Option Tips
This Week - Weekly Sector Report
Live Hourly Stock and Nifty Trend
Click Here : Free Nifty Intraday Chart Live
Today Nifty Stocks Support and Resistance Level
Today Free Nifty Option Tips
Today Free Banknifty Option Tips
Today Free Stock Option Tips
This Week - Weekly Sector Report
Live Hourly Stock and Nifty Trend
The stocks of pharmaceutical companies are seen rising next week due to likely buying-on-dips by investors. Long term investors should use any rise in these stocks to sell their positions, as the
medium-term trend for the sector remains negative. Pharmaceutical companies have been among the worst performers this year, as increased pricing pressure in their largest drug market, the US and heightened regulatory scrutiny in recent years have suppressed revenues and profit margins. We may see a relief rally in the short term, but investors May outperform benchmarks, snap 7- week trend should sell on those rallies. The government plans to make it mandatory for chemists at pharmacy shops to inform patients about the generic drug substitute for a branded drug are likely to weigh on these stocks. Buying by mutual funds is expected next week, with mid-cap pharmaceutical companies being preferred over their large-cap peers.
Source : Cogencis Information Services Ltd.
Free Stock Options :Register To Get 2 days Trial Tips
Free Intraday Tips : Join Our Whatsapp No : 9841986753
Free Commodity Tips : Join our Whatsapp No : 9094047040